References
- Simpson, K.; Jarvis, B. Drugs 2000, 59, 301 https://doi.org/10.2165/00003495-200059020-00020
- Bender, M. L.; Komiyama, M. Cyclodextrin Chemistry; Springer Verlag: New York, 1978; pp 1
- Saenger, W. Angew. Chem. Int. Ed. Engl. 1980, 19, 344 https://doi.org/10.1002/anie.198003441
- Szejtli, J. Cyclodextrin Technology; Kluwer: Dordrecht, 1988; pp 450
- Vogtle, F. Supramolecular Chemistry: An Introduction; John Wiley & Sons Ltd: New York, 1991
- Wenz, G. Angew. Chem. Int. Ed. Engl. 1994, 33, 803 https://doi.org/10.1002/anie.199408031
- Esclusa-Diaz, M. T.; Gayo-Otero, M.; Perez-Marcos, M. B.; Villa- Jato, J. L. Int. J. Pharm. 1996, 142, 183 https://doi.org/10.1016/0378-5173(96)04666-2
- Obaidat, A. A.; Matalgah, S. M.; Najib, N. M. Acta Pharm. 2002, 52, 9
- Torres-Labandeira, J. J.; Blanco-Mendez, J.; Villa-Jato, J. L. STP Pharm. Sci. 1994, 4, 235
- Szejtli, J. Med. Res. Rev. 1994, 14, 353 https://doi.org/10.1002/med.2610140304
- Schneider, H.-J.; Hacket, F.; Rudiger, V.; Ikeda, H. Chem. Rev. 1998, 98, 1755 and references cited therein https://doi.org/10.1021/cr970019t
- Rekharsky, M. V.; Goldberg, R. N.; Schwarz, F. P.; Tewari, Y. B.; Ross, P. D.; Yamashoji, Y.; Inoue, Y. J. Am. Chem. Soc. 1995, 117, 8830 https://doi.org/10.1021/ja00139a017
- Nakajima, T.; Sunagawa, M.; Hirohashi, T.; Fujioka, F. Chem. Pharm. Bull. Jpn. 1984, 32, 400
- Qi, Z. H.; Mak, V.; Diaz, L.; Grant, D. M.; Chang, C. J. Org. Chem. 1991, 56, 1537 https://doi.org/10.1021/jo00004a037
- Neuhaus, D.; Williamson, M. In The Nuclear Overhauser Effect in Structural and Conformational Analysis; VCH Publishers: New York, 1989; p 1
- Szejtli, J. Chem. Rev. 1998, 98, 1743 https://doi.org/10.1021/cr970022c
- Ali, S. M.; Maheshwari, A.; Asmat, F. Pharmazie 2004, 59, 653
- Ali, S. M.; Asmat, F.; Maheshwari, A. IL Farmaco 2004, 59, 835 https://doi.org/10.1016/j.farmac.2004.05.009
- Fronza, G.; Mele, A.; Redenti, E.; Ventura, P. J. Pharm. Sci. 1992, 81, 1162 https://doi.org/10.1002/jps.2600811206
- Yoshida, N. J. Chem. Soc. Perk. Trans. 2 1995, 2249
Cited by
- Complexation of Fluvastatin Sodium with β-Cyclodextrin: NMR Spectroscopic Study in Solution vol.55, pp.3-4, 2006, https://doi.org/10.1007/s10847-006-9099-9
- 1H NMR spectroscopic investigation of β-cyclodextrin inclusion compounds with parecoxib vol.59, pp.1-2, 2007, https://doi.org/10.1007/s10847-007-9314-3
- High Resolution NMR Spectroscopic Study of Complexation of Hydroxyzine Hydrochloride with β-Cyclodextrin in Aqueous Solution vol.53, pp.4, 2006, https://doi.org/10.1002/jccs.200600115
- Investigation of the binding of roxatidine acetate hydrochloride with cyclomaltoheptaose (β-cyclodextrin) using IR and NMR spectroscopy vol.346, pp.13, 2005, https://doi.org/10.1016/j.carres.2011.07.003
- Structure determination of fexofenadine‐α‐cyclodextrin complex by quantitative 2D ROESY analysis and molecular mechanics studies vol.50, pp.4, 2005, https://doi.org/10.1002/mrc.3807
- Antimicrobial Effect of α- or β-Cyclodextrin Complexes with Trans-Cinnamaldehyde Against Staphylococcus aureus and Escherichia coli vol.33, pp.3, 2005, https://doi.org/10.1080/07373937.2014.957388
- Characterization of a single‐isomer carboxymethyl‐beta‐cyclodextrin in chiral capillary electrophoresis vol.38, pp.15, 2005, https://doi.org/10.1002/elps.201700004